The FDA considers making some drugs for diabetes, asthma, and other ailments available over the counter.
The Scientist
Most Recent
Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?
The Pediatric Research Equity Act (PREA) of 2003 requires that companies developing new drugs that could be used to treat a condition in children perform clinical trials in kids before winning FDA approval. The Best Pharmaceuticals for Children Act (
Studies on safety, efficacy, or dosing of drugs in children, or on nutritional supplements, are not run-of-the-mill.
With an eye to understanding animal regeneration, Alejandro Sánchez Alvarado has turned a freshwater planarian into a model system to watch.
For the first time researchers have demonstrated the molecular tango that gives rise to repeating patterns in developing animal embryos.
The federal agency finally breaks out some information on what it might take to get generic biological drugs approved.
Imaging cell cytoskeletons during early embryonic development leads researchers to uncover a new regulator of cell shape
Current and former employees of the US Food and Drug Administration have filed suit, alleging that their employer spied on them for whistleblowing.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
